SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Alphabet Inc. to the U.S. Securities and Exchange Commission. The reporting period covers holdings as of December 31, 2023. This document discloses Alphabet's equity securities held in the United States, detailing the issuer, class of security, CUSIP, value, and voting authority.
Key Financial Metrics and Holdings
The filing does not report Alphabet's internal revenue, profit, cash flow, or debt. Instead, it lists the market value of Alphabet's investment portfolio in other public companies. Key metrics include:
- Total Portfolio Value: The filing lists individual positions but does not provide a consolidated total portfolio value in the text provided.
- Largest Reported Positions (by Value):
- Arm Holdings PLC: $147,343,114
- CrowdStrike Holdings Inc: $327,749,944
- Dexcom Inc: $456,885,110
- Revolution Medicines Inc: $150,699,002
- Snowflake Inc: $106,585,196
- UiPath Inc: $174,732,931
- Verve Therapeutics Inc: $169,628,736
- Voting Authority: Alphabet reports "Sole" voting authority for the majority of listed positions, with some "Shared" or "None" authority noted for specific holdings.
Material Changes and Portfolio Composition
The filing text provided is a static snapshot of holdings as of the reporting date. It does not contain comparative data against the prior quarter (September 30, 2023) or year-over-year changes. Therefore, material changes in position size or new entries cannot be determined from this specific text alone. The portfolio is heavily concentrated in the technology and biotechnology/healthcare sectors.
Guidance, Risks, and Management Commentary
Guidance and Outlook: This filing type does not include management commentary, financial guidance, or future outlooks for Alphabet Inc. or the invested companies.
Risks and Contingencies: The filing includes a standard disclaimer stating that the SEC has not reviewed the information for accuracy or completeness. No specific risk factors or contingencies regarding the investments are detailed in the table.
Unusual Items: No unusual items are flagged in the text. The "Investment Discretion" column indicates "DFND" (likely referring to a specific fund or discretionary account code) for all entries.
Investor Verification Checklist
- Verify the total aggregate value of Alphabet's 13F portfolio by summing the "Value" column, as the total is not explicitly stated in the provided text.
- Compare these holdings against the previous quarter's 13F filing to identify new entries, exits, or significant position changes.
- Confirm the voting authority status (Sole vs. Shared) for high-value positions like Dexcom and Arm Holdings to understand Alphabet's influence.
- Review the sector concentration to assess Alphabet's strategic investment focus in AI, genomics, and enterprise software.
- Check for any footnotes in the full filing that may explain the "DFND" designation or specific valuation adjustments.